Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2021)
Palisade Bio (PALI) reported Amortizatization of Intangibles of $5000.0 for Q4 2021, down 97.06% year-over-year from $170000.0 in Q4 2020, and down 96.18% quarter-over-quarter from $131000.0 in Q3 2021.
Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Palisade Bio (PALI) has 2 years of Amortizatization of Intangibles data on file, last reported at $5000.0 in Q4 2021.
- Amortizatization of Intangibles for Q4 2021 came in at $5000.0, down 97.06% year-over-year; the trailing twelve-month figure through Sep 2022 was $5000.0 (down 99.8% YoY), and the FY2021 annual result was $2.3 million, up 1057.92% from the prior year.
- Amortizatization of Intangibles fell to $5000.0 in Q4 2021 per PALI's latest filing, from $131000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.6 million in Q1 2021 and troughed at $5000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.59 Mn |
| Dec 31, 2020 | 170,000.00 |
| Dec 31, 2020 | 170,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Sep 30, 2020 | 20,000.00 |